Cytotoxicity of ginkgolic acid in HepG2 cells and primary rat hepatocytes

Toxicology Letters

Volumn 187, Issue 3, 2009, Pages 131-136

  Liu, Z H ^a   Zeng, S ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

CYP induction; CYP inhibition; Cytotoxicity; Ginkgolic acid; HepG2 cell; MTT; Rat hepatocyte

Indexed keywords

4 METHYLPYRAZOLE; ALKYLPHENOL; ALPHA NAPHTHOFLAVONE; CYTOCHROME P450; GINKGOLIC ACID; KETOCONAZOLE; QUININE; RIFAMPICIN; SULFAPHENAZOLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ANTAGONISM; DRUG METABOLISM; HUMAN; HUMAN CELL; LIVER CELL; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BENZOFLAVONES; BETA-NAPHTHOFLAVONE; CELL LINE, TUMOR; CELL SURVIVAL; CYTOCHROME P-450 ENZYME SYSTEM; HEPATOCYTES; HUMANS; ISOENZYMES; KETOCONAZOLE; LIVER; MALE; MICROSOMES, LIVER; PYRAZOLES; QUININE; RATS; RATS, SPRAGUE-DAWLEY; SALICYLIC ACIDS; SULFAPHENAZOLE;

RATTUS;

EID: 64249120290     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.02.012     Document Type: Article

References (41)

1. Baron-Ruppert G., and Luepke N.P. Evidence for toxic effects of alkylphenols from Ginkgo biloba in the hen's egg test (HET). Phytomedicine 8 (2001) 133-138
2. Baldwin S.J., Bloomer J.C., Smith G.J., Ayrtin A.D., Clarke S.E., and Chenery R.J. Ketoconazole and sulfaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica 25 (1995) 261-270
3. Barbara A., Dagmar S., Christine S., Susanne K., and Josef K. Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur. J. Pharmacol. 430 (2001) 1-7
4. Dresser G.K., Spence J.D., and Bailey D.G. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin. Pharmacokinet. 38 (2000) 41-57
5. Newton D.J., Wang R.W., and LU A.Y.H. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. DMD 23 (1994) 154-158
6. Fry J.R., Hammond A.H., Atmaca M., Dhanjal P., and Wilkinson D.J. Toxicity testing with hepatocytes: some methodological aspects. ATLA-Alt. Lab. Anim. 23 (1995) 91-96
7. Fuzzati N., Pace R., and Villa F. A simple HPLC-UV method for the assay of ginkgolic acids in Ginkgo biloba extracts. Fitoterapia 74 (2003) 247-256
8. Gibson G.G., and Skett P. Introduction to Drug Metabolism. Second Ed. (1994), Blackie Academic & Professional, London pp. 217-219
9. Gonzalez F.J., Nebert D.W., Hardwick J.P., and Kasper C.B. Complete cDNA and protein sequence of a pregnenolone 16-carbonitrile-induced cytochrome P-450. J Biol Chem 260 (1985) 7435-7441
10. Gradolatto A., Canivenc-Lavier M.C., Basly J.P., Siess M.H., and Teyssier C. Metabolisms of apigenin by rat liver phase I and phase II enzymes and by isolated perfused rat liver. DMD 32 (2004) 58-65
11. Halpert J.R., Guengerich F.P., Bend J.R., and Correia M.A. Contempory issues in toxicology. Selective inhibitors of cytochromes P450. Toxicol. Appl. Pharmacol. 125 (1994) 163-175
12. Hammond A.H., and Fry J.R. Effects of culture duration, cytocrome P450 inhibition and gluthatione depletion on toxicity of diverse xenobiotics. Toxicol. In Vitro. 10 (1996) 315-321
13. Hausen B.M. The sensitizing capacity of ginkgolic acids in guinea pigs. Am. J. Contact. Dermat. 9 (1998) 146-148
14. Hecker H., Johannison R., Koch E., and Siegersa C.P. In vitro evaluation of the cytotoxic potential of alkylphenols from Ginkgo biloba L. Toxicology 177 (2002) 167-177
15. Jover R., Ponsoda X., Castell J.V., and Gómez-Lechón M.J. Evaluation of the cytotoxicity of ten chemicals on human culture hepatocytes: predictability of human toxicity and comparison with rodent cell culture systems. Toxicol. In Vitro. 6 (1992) 47-52
16. Kobayashi S., Murray S., Watson D., Sesardic D., Davies D.S., and Boobis A.R. The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochem. Pharmacol. 38 (1989) 2795-2799
17. Koch E., Jaggy H., and Chatterjee S.S. Evidence for immunotoxic effects of crude Ginkgo biloba L. leaf extracts using the popliteal lymph node assay in the mouse. Int. J. Immunopharmacol. 22 (2000) 229-236
18. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
19. Martin P., Riley R., Back D.J., and Owen A. Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells. Br. J. Pharmacol. 153 (2008) 805-819
20. Matsuda H., Kinoshita K., and Sumida A. Taurine modulates induction of cytochrome P450 3A4 mRNA by rifampicin in the HepG2 cell line. Biochim. Biophys. Acta 2002 (2002) 1593-1598
21. Melo P.S., Durán N., and Haun M. Derivatives of dehydrocrotonin, a diterpene lactone isolated from Croton cajucara: cytotoxicity in rat cultured hepatocytes and in V79 cells. Hum. Exp. Toxicol. 21 (2002) 281-288
22. Moldeus P., Hogberg J., and Orrenius S. Isolation and use of liver cells. Methods Enzymol. 52 (1978) 60-71
23. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
24. Mugford C.A., and Kedderis G.L. Sex-dependent metabolism of xenobiotics. Drug Metab. Rev. 30 (1998) 441-498
25. Murray M., and Reid G.F. Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol. Rev. 42 (1990) 85-101
26. Paillard F., Finot F., Mouche I., Prenez A., and Vericat J.A. Use of primary cultures of rat hepatocytes to predict toxicity in the early development of new chemical entities. Toxicol. In Vitro 13 (1999) 693-700
27. Paine A.J. The maintenance of cytochrome P450 in rat hepatocyte culture: some applications of liver cell cultures to the study of drug metabolism, toxicity and the induction of the P450 system. Chem. Biol. Interact. 74 (1990) 1-31
28. Ueda R., Iketaki H., Nagata K., Kimura S., Gonzalez F.J., Kusano K., Yoshimura T., and Yamazoe T. A Common Regulatory Region Functions Bidirectionally in Transcriptional Activation of the Human CYP1A1 and CYP1A2 Genes. Mol. Pharmacol. 69 (2006) 1924-1930
29. Riley R.J., Maggs J.L., Lambert C., Kitteringham N.R., and Park B.K. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. Br. J. Clin. Pharmacol. 26 (1988) 577-588
30. Rodriguez-Antona C., Donato M.T., Boobis A., Edwards R.J., Watts P.S., and Castell J.V. Gomez-Lechon, Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica 32 (2002) 505-520
31. Rueff J., Chiapella C., Chipman J.K., Darroudi F., Silva I.D., Bogaert M.D., Fonti E., Glatt H.R., Isern P., Laires A., Léonard A., Llagostera M., Mossesso P., Natarajan A.T., Palitti F., Rodrigues A.S., Schinoppi A., Turchi G., and W-Schneider G. Development and validation of alternative metabolic systems for mutagenicity testing in short-term assays. Mutat. Res. 353 (1996) 151-176
32. Siegers C.P. Cytotoxicity of alkylphenols from Ginkgo biloba. Phytomedicine 6 (1999) 281-283
33. Smith C.M., Faucette S.R., Wang H., and Lecluyse E.L. Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers. J. Biochem. Mol. Toxicol. 19 (2005) 96-108
34. Westerink W.M.A., and Schoonen W.G.E.J. Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol. In Vitro 21 (2007) 1592-1602
35. Westerink W.M.A., and Schoonen W.G.E.J. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol. In Vitro 21 (2007) 1581-1591
36. Westerink W.M.A., Stevenson J.C.R., and Schoonen W.G.E.J. Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition. Arch. Toxicol. 82 (2008) 909-921
37. Westendorf J., and Regan J. Induction of DNA strand-breaks in primary rat hepatocytes by ginkgolic acids. Pharmazie 55 (2000) 864-865
38. Yang L.Q., Wu X.Y., and Chen J. Determination of ginkgolic acids by high performance liquid chromatography. Acta. Pharm. Sin. 37 (2002) 555-558
39. Yoshitomi K., Ikemoto J., Takahashi H., Miki M., Namba, and Asahi S. Establishment of the transformants expressing human cytochrome P450 subtypes in HepG2, and their applications on drug metabolism and toxicology. Toxicol. In Vitro 15 (2001) 245-256
40. Yu L.S., Yao T.W., and Zeng S. In vitro metabolism of zolmitriptan in rat cytochromes induced with β-naphthoflavone and the interaction between six drugs and zolmitriptan. Chem. Biol. Interact. 146 (2003) 263-272
41. Zhou S., Chan E., Duan W., Huang M., and Chen Y.Z. Drug bioactivation, covalent binding to target proteins and toxicity relevance. Drug Metab. Rev. 37 (2005) 41-213